GO
Loading...

Ackman explains Valeant bid

Monday, 9 Jun 2014 | 7:52 AM ET

Bill Ackman, founder and CEO of Pershing Square Capital Management, answers why he thinks Valeant's potential takeover of Allergan is beneficial, and the 'unprecedented' terms in the bid.